This increase may be the result of expanded continuing medical education regarding ADHD that has raised physician awareness, as well as modifications in diagnostic criteria.
Investigators conducted a retrospective observational study to assess the impact of psychostimulant medication on BMI and height in a group of children and adolescents with ADHD.
Medication continuity in youth with ADHD is affected by several potentially modifiable factors that could be productive targets of intervention for pediatricians.
These findings offer preliminary evidence of the validity of the short UPPS-P-C to screen for impulsivity traits in both typically developing children and in those with ADHD.
The results of the study point to effective alternatives to psychopharmacologic treatments with methylphenidate for patients who experience nonresponse, contraindications, or adverse events, or for patients who prefer nonpsychopharmacologic treatments.
These findings can inform clinical practice in that type 2 diabetes should be considered in ADHD even in the absence of other known risk factors.
While overall prescribing of medications decreased compared with the early 2000s, the use of ADHD medication, asthma medicine, and contraceptive use increased while use of antibiotics, antihistamines, and upper respiratory combination medications decreased.
For children with ADHD, participation in after-school activities is associated with reduced odds of moderate-to-severe ADHD.
ADHD's many deficits cannot be ameliorated by pharmacotherapy alone. Researchers and clinicians are investigating computer interventions and physical activity that get to the root of the ADHD domain, such as inattention, memory, or time management.
The results of this study suggest that children prenatally exposed to substances should receive early mental health assessment.
These data confirmed the increased risk for psychiatric disorders in women with PCOS, and indicated an increased risk for ADHD and ASD in their children.
These results may be used to improve early identification of at-risk siblings based on a proband diagnosis of ADHD.
Recognizing the increased risk for mood disorders in children with ASD and ADHD may be useful for clinicians and parents in developing proper screening and treatment strategies.
If replicated, the novel findings in this study may have important implications for assessing sluggish cognitive tempo in ADHD.
Investigators sought to determine the risk for developing secondary ADHD 5 to 10 years after traumatic brain injury in children and adolescents.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Lithium Monotherapy Effective in Treating Bipolar Disorder in Children
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Computerized Training Programs for Schizophrenia Improve Cognitive Functioning
- Antidepressant Effects of Ketamine Appear to Require Opioid System Activation
- Attention-Deficit/Hyperactivity Disorder Increasing Among US Children and Adolescents
- Cost-Effective Telehealth Alternatives for Veterans With Depression
- Polygenic Risk Scores Could Aid in Identifying Bipolar Disorder, Schizophrenia
- Brief Impression Questionnaire Useful in Schizophrenia Diagnoses